# Jun SHAO

> Jun SHAO is a Series A investor at CAS Investment Management backing Medical and Biopharma. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [CAS Investment Management](https://shizune.co/investors/profile/cas-investment-management)
- Total investments: 1
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/shao-jun-b9830b23

Jun SHAO is a Series A investor at CAS Investment Management focused on Medical and Biopharma. Jun SHAO

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biopharma | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Artificial Intelligence | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Phil Rivers Technology | Zheyuan Technology is an AI pharmaceutical R&D solution provider. | $14.2M | Series A |  |  |

1 of 1 investments shown.

## Co-investors
- [ChemPartner](https://shizune.co/investors/profile/chempartner) — VC Fund, 1 deal together
- [Zeyfund](https://shizune.co/investors/profile/zeyfund) — VC Fund, 1 deal together

## About CAS Investment Management

VC Fund · Beijing, China

CAS Investment Management Co., Ltd. (abbreviated as CASI)' s controlling shareholder is Chinese Academy of Sciences Holdings Co., Ltd. (CAS Holdings www.casholdings.com.cn ) and has State-owned Assets Supervision and Administration Commission of the State Council (SASAC http://www.sasac.gov.cn/n1180/index.html ) and anemployee-owned company as shareholders. Its predecessor is the Chinese National Economic Council-CAS Scientific and Technological Promotion & Economic Development Foundation.With a mission of “providing capital support and value-added service to industrial leaders, and promoting them to be outstanding companies with international competitiveness”, CASI is dedicated to be a Chinese leading PE fund manager.

3 contacts available at CAS Investment Management.

| Name | Title | Profile |
| --- | --- | --- |
| Jun SHAO | CFO | https://shizune.co/investors/profile/jun-shao |
| Qianhong LIU | CEO | https://shizune.co/investors/profile/qianhong-liu |
| Sun Hua | Chairman | https://shizune.co/investors/profile/sun-hua-88e6 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Jun SHAO invest in?

Jun SHAO invests primarily in Medical, Biopharma and Health Care startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co